Literature DB >> 26622832

Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation.

Takatoshi Tokudome1, Akiko Sasaki1, Mayumi Tsuji1, Yuko Udaka1, Hideto Oyamada1, Hiromichi Tsuchiya1, Katsuji Oguchi1.   

Abstract

Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a tumor suppressor gene that induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway. Glioblastoma (GBM) is a brain tumor that is resistant to irradiation and chemotherapy and, thus, is difficult to cure. GBM stem-like cells (GSCs) have been implicated as a cause of this resistance. microRNA (miRNA/miR) inhibits the expression of proteins. The objective of the present study was to identify miRNAs that target PTEN, which induces apoptosis, in irradiation-resistant GSCs. When the expression of miRNAs was examined in GSCs irradiated at 60 Gy using the human GBM A172 cell line, the expression of PTEN-targeting miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p was significantly higher in irradiated GSCs than in non-irradiated cells, and the PTEN expression levels, as revealed by immunostaining, were lower in the irradiated GSCs than in the non-irradiated cells. These results suggested that the expression of PTEN was suppressed through the overexpression of PTEN-targeting miRNAs in GSCs following irradiation.

Entities:  

Keywords:  glioblastoma; glioblastoma stem-like cell; microRNA; phosphatase and tensin homolog deleted on chromosome 10

Year:  2015        PMID: 26622832      PMCID: PMC4579916          DOI: 10.3892/ol.2015.3594

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis.

Authors:  Ji-Hyun Chung; Charis Eng
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

2.  Clinical value of CD133 and nestin in patients with glioma: a population-based study.

Authors:  Rikke H Dahlrot; Steinbjørn Hansen; Stine S Jensen; Henrik D Schrøder; Jacob Hjelmborg; Bjarne W Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.

Authors:  E Rao; C Jiang; M Ji; X Huang; J Iqbal; G Lenz; G Wright; L M Staudt; Y Zhao; T W McKeithan; W C Chan; K Fu
Journal:  Leukemia       Date:  2011-11-25       Impact factor: 11.528

Review 4.  The evolving landscape of glioblastoma stem cells.

Authors:  Kenneth Yan; Kailin Yang; Jeremy N Rich
Journal:  Curr Opin Neurol       Date:  2013-12       Impact factor: 5.710

Review 5.  Pathology and molecular genetics of astrocytic gliomas.

Authors:  Guido Reifenberger; Vincent Peter Collins
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

6.  Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.

Authors:  Christina L Appin; Jingjing Gao; Candace Chisolm; Mike Torian; Dianne Alexis; Cristina Vincentelli; Matthew J Schniederjan; Costas Hadjipanayis; Jeffrey J Olson; Stephen Hunter; Chunhai Hao; Daniel J Brat
Journal:  Brain Pathol       Date:  2013-01-30       Impact factor: 6.508

Review 7.  Epidemiologic and molecular prognostic review of glioblastoma.

Authors:  Jigisha P Thakkar; Therese A Dolecek; Craig Horbinski; Quinn T Ostrom; Donita D Lightner; Jill S Barnholtz-Sloan; John L Villano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-22       Impact factor: 4.254

Review 8.  The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.

Authors:  Amancio Carnero; Carmen Blanco-Aparicio; Oliver Renner; Wolfgang Link; Juan F M Leal
Journal:  Curr Cancer Drug Targets       Date:  2008-05       Impact factor: 3.428

9.  Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia.

Authors:  Yasuo Yamanaka; Hiroyuki Tagawa; Naoto Takahashi; Atsushi Watanabe; Yong-Mei Guo; Keiko Iwamoto; Junsuke Yamashita; Hirobumi Saitoh; Yoshihiro Kameoka; Norio Shimizu; Ryo Ichinohasama; Ken-ichi Sawada
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

10.  Protein tyrosine phosphatases PTP-1B, SHP-2, and PTEN facilitate Rb/E2F-associated apoptotic signaling.

Authors:  Liza D Morales; Edgar A Casillas Pavón; Jun Wan Shin; Alexander Garcia; Mario Capetillo; Dae Joon Kim; Jonathan H Lieman
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

View more
  9 in total

Review 1.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

2.  Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6.

Authors:  Jielu Hao; Qingqing Wei; Shuqin Mei; Lin Li; Yunchao Su; Changlin Mei; Zheng Dong
Journal:  Kidney Int       Date:  2016-09-09       Impact factor: 10.612

3.  The Emerging Field of Noncoding RNAs and Their Importance in Pediatric Diseases.

Authors:  Rui Zhou; Piyush Joshi; Keisuke Katsushima; Weihong Liang; Wei Liu; Neil A Goldenberg; George Dover; Ranjan J Perera
Journal:  J Pediatr       Date:  2020-06       Impact factor: 4.406

Review 4.  Nutritional and Nanotechnological Modulators of Microglia.

Authors:  Dusica Maysinger; Issan Zhang
Journal:  Front Immunol       Date:  2016-07-15       Impact factor: 7.561

5.  MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas.

Authors:  Ying Yuan; Hua Zhang; Xuexia Liu; Zhongming Lu; Guojun Li; Meixia Lu; Xiaofeng Tao
Journal:  Oncotarget       Date:  2017-04-06

6.  Characterization of microRNAs expression profiles in human dental-derived pluripotent stem cells.

Authors:  Xiaobing Tan; Qingyuan Dai
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

Review 7.  miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review.

Authors:  Maria Teresa Di Martino; Mariamena Arbitrio; Daniele Caracciolo; Alessia Cordua; Onofrio Cuomo; Katia Grillone; Caterina Riillo; Giulio Caridà; Francesca Scionti; Caterina Labanca; Caterina Romeo; Maria Anna Siciliano; Maria D'Apolito; Cristina Napoli; Martina Montesano; Valentina Farenza; Valentina Uppolo; Michele Tafuni; Federica Falcone; Giuseppe D'Aquino; Natale Daniele Calandruccio; Francesco Luciano; Licia Pensabene; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Mol Ther Nucleic Acids       Date:  2022-02-11       Impact factor: 8.886

8.  Prognostic Role of MicroRNA 222 in Patients with Glioma: A Meta-analysis.

Authors:  Yanlin Song; Jing Zhang; Min He; Jianguo Xu
Journal:  Biomed Res Int       Date:  2020-09-25       Impact factor: 3.411

9.  Allicin protects against myocardial I/R by accelerating angiogenesis via the miR-19a-3p/PI3K/AKT axis.

Authors:  Mengru Liu; Peng Yang; Dongliang Fu; Tong Gao; Xinyi Deng; Mingjing Shao; Jiangquan Liao; Hong Jiang; Xianlun Li
Journal:  Aging (Albany NY)       Date:  2021-10-04       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.